Pricing Log in Create free account

Sarepta Therapeutics, Inc. (SRPT) vs First Tracks Biotherapeutics, Inc. (TRAX)

Sarepta Therapeutics, Inc. and First Tracks Biotherapeutics, Inc. are both Biotechnology companies. Sarepta Therapeutics, Inc. and First Tracks Biotherapeutics, Inc. are of similar size ($1.9B and $1.9B). First Tracks Biotherapeutics, Inc. has the higher net margin (0.00% vs −5.86%) and the higher return on invested capital (0.00% vs −2.03%). Across the 11 metrics below, First Tracks Biotherapeutics, Inc. leads on 7 and Sarepta Therapeutics, Inc. on 4.

Valuation

Metric SRPT TRAX Biotechnology median
P/E n/m n/m 10.60
P/S 0.96 n/m 9.40
P/B 1.23 11.31 2.13
Price to free cash flow 11.07 n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 0.95 n/m 9.02
Earnings yield (6.21%) (10.82%) (32.88%)
Free cash flow yield 9.04% (6.57%) (23.13%)

Profitability

Metric SRPT TRAX Biotechnology median
Gross margin 0.00% — 68.51%
Operating margin (2.50%) 0.00% 0.00%
Net margin (5.86%) 0.00% 0.00%
Free cash flow margin 9.02% 0.00% 0.00%
Return on equity (8.05%) 0.00% (51.96%)
Return on assets (3.44%) 0.00% (46.06%)
Return on invested capital (2.03%) 0.00% 0.00%

Growth

Metric SRPT TRAX Biotechnology median
Revenue growth (TTM) (18.95%) — 6.76%
EPS growth (last fiscal year) (404.70%) — 29.88%
Revenue growth, 5-year CAGR 32.41% — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric SRPT TRAX Biotechnology median
Debt to equity 0.56 0.00 0.00
Current ratio 3.46 9.16 4.97
Net debt to EBITDA 0.17 — 1.01

Dividend

Metric SRPT TRAX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric SRPT TRAX Biotechnology median
Market cap 1.86b 1.91b 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack